Access Pharmaceuticals, Inc.

Access Pharmaceuticals, Inc.

Sector: Pharmaceutical Preparations Region: TX, United States

: | OTC Markets: ACCP

Similar to: Hutchison China MediTech Ltd., Recordati SpA, BioGaia AB

Access Pharmaceuticals, Inc. is an emerging pharmaceutical company engaged in the development of novel therapeutics for the treatment of cancer and supportive care of cancer patients. It is focused on developing a range of pharmaceutical and medical device products primarily based upon nanopolymer chemistry technologies and other drug delivery technologies. The company's products are MuGard, ProLindac, Cobalamin, Thiarabine, CobOral and CobaCyte. The company was founded in 1974 and is headquartered in Dallas, TX.

News & Analysis

You may also be interested in: